These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30473550)

  • 1. China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issues.
    He J; Tang M; Ye Z; Jiang X; Chen D; Song P; Jin C
    Biosci Trends; 2018; 12(5):445-449. PubMed ID: 30473550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interpretation of China national essential medicines list 2018.
    Zuo W; Mei D; Sun W; Tang X; Niu Z; Gao D; Zhang B
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):191-200. PubMed ID: 31914825
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.
    Chen W; Tang S; Sun J; Ross-Degnan D; Wagner AK
    BMC Health Serv Res; 2010 Jul; 10():211. PubMed ID: 20637116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji.
    Huang Y; Jiang Y; Zhang L; Mao W; van Boven JFM; Postma MJ; Chen W
    BMC Health Serv Res; 2018 Mar; 18(1):218. PubMed ID: 29587742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of government agencies and other actors in influencing access to medicines in three East African countries.
    Odoch WD; Dambisya Y; Peacocke E; Sandberg KI; Hembre BSH
    Health Policy Plan; 2021 Apr; 36(3):312-321. PubMed ID: 33569583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer medicines in Pakistan: An analysis of essential medicines lists.
    Shukar S; Anjum R; Zhang J; Babar ZU; Mobeen I; Yang C
    J Oncol Pharm Pract; 2024 Jan; 30(1):46-54. PubMed ID: 37006130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
    Guan X; Hu H; Man C; Shi L
    Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China.
    Tang Y; Liu C; Zhang X
    Appl Health Econ Health Policy; 2017 Feb; 15(1):57-64. PubMed ID: 27613726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.
    Xu S; Bian C; Wang H; Li N; Wu J; Li P; Lu H
    BMC Health Serv Res; 2015 Sep; 15():403. PubMed ID: 26394615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of Pediatric Formulations in Public Health Care System in India: A Case Study.
    Roy V; Singhal S; Tayal H; Dubey AP
    Indian J Pediatr; 2021 Mar; 88(3):227-234. PubMed ID: 32086758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug shortages in China: a cross-sectional study.
    Song Y; Li J; Zhao F; Jin P
    BMC Health Serv Res; 2023 May; 23(1):438. PubMed ID: 37143100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital pharmacists' knowledge of and attitudes towards the implementation of the National Essential Medicines System: a questionnaire survey in western China.
    Shen Q; Yang C; Chang J; Wu L; Zhu W; Lv B; Ye D; Yang S; Fang Y
    BMC Health Serv Res; 2016 Jul; 16():292. PubMed ID: 27439446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impacts of implementation of National Essential Medicines Policies on primary healthcare institutions: a cross-sectional study in China.
    Guo Z; Guan X; Shi L
    BMC Health Serv Res; 2017 Nov; 17(1):723. PubMed ID: 29132361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China.
    Xie X; Jin X; Zhang L; Sun H; Shen A; Huang X; Sun Y
    BMC Health Serv Res; 2018 Oct; 18(1):812. PubMed ID: 30352585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent Funded Access to Medicines.
    Andreassen T
    Dev World Bioeth; 2015 Dec; 15(3):152-61. PubMed ID: 24750573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatima Suleman: making medicines more widely available.
    Bull World Health Organ; 2017 Dec; 95(12):800-801. PubMed ID: 29200520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.